Pompe Disease Market Report 2022: Market Capacity, Market Overview, Consumption, Status and Prediction 2030

Increasing prevalence of Pompe Disease is one of the key factors driving Pompe Disease market revenue growth

The global Pompe Disease market size reached USD 1,386.09 Million in 2021 and is expected to register a revenue CAGR of 3.9% during the forecast period, according to a latest analysis by Emergen Research. Increasing prevalence of Pompe Disease, rising number of clinical studies and trials in the field of Pompe-disease-based treatments, and introduction of novel and advanced screening platforms for early diagnosis are crucial factors driving market revenue growth.

Pompe disease is a hereditary, frequently fatal ailment that affects the heart and skeletal muscles. It is thought to affect one in every 40,000 births, according to the National Institute of Neurological Disorders and Stroke. Mutations in a gene that produces an enzyme called acid alpha-glucosidase cause it (GAA). Many researchers are trying to bet­ter understand the earliest features and manifestations of late-onset Pompe disease novel screening platforms such as newborn screening.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/1081

According to the Muscular Dystrophy Association (MDA), 20 states are now testit newborns through newborn screening platforms for Pompe Disease, the latest neuromuscular disease, which is being added to a list of significant genetic disorders for which children can be tested shortly after delivery in the United States. We are investi­gating if starting people early on the right dose of ERT could impact outcomes. Targeted screening of at-risk individuals, as well as general newborn screening, can lead to early detection and treatment of Pompe disease patients, potentially improving clinical outcomes. Other advanced and creative diagnostic systems, such as enzyme activity assessment using a tandem-mass-spectrometry-based assay for Pompe disease, are being produced, examined, and validated in large screening programs.

The report further sheds light on the competitive landscape of the Pompe Disease Market to offer the readers an advantage over others. The competitive landscape section of the report talks about the recent advancements in the RD and technologies undertaken by the prominent players, along with their strategic business expansion plans, product launches, and brand promotions. The report pays special attention to the strategic alliances such as mergers and acquisitions, joint ventures, collaborations, agreements, corporate and government deals, and others adopted by the prominent players of the industry to expand their market presence and gain a substantial market position.

Request a discount on the report @ https://www.emergenresearch.com/request-discount/1081

Emergen Research has segmented global Pompe Disease market on the basis of type, treatment type, end-use and region:

Type Outlook (Revenue, USD Million; 2019-2030)

Infantile-Onset Pompe Disease (IOPD)

Late-Onset Pompe Disease (LOPD)

Treatment Type Outlook (Revenue, USD Million; 2019-2030)

Enzyme Replacement Therapy (ERT)

Chaperone Therapy

Substrate Replacement Therapy (SRT)

Others

End-Use Outlook (Revenue, USD Million; 2019-2030)

Hospitals

Diagnostic Centers

Others

To know more about the report @ https://www.emergenresearch.com/industry-report/pompe-disease-market

Regional Segmentation

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

The report also studies the key companies of the Pompe Disease market along with analysis of their business strategies, MA activities, investment plans, product portfolio, financial standing, gross profit margin, and production and manufacturing capacities.

Key players include

Sanofi S.A.,

Amicus Therapeutics, Inc.,

BioMarin Pharmaceutical,

Valerion Therapeutics,

Oxyrane,

Genzyme Corporation,

EpiVax, Inc.,

Bayer AG,

Audentes Therapeutics, and

Sangamo Therapeutics

Buy Now @ https://www.emergenresearch.com/select-license/1081

Highlights of Table of Contents (TOC):

Overview of Global Pompe Disease Market

Competitive analysis of the Pompe Disease market

Regional analysis of Global Pompe Disease market production and revenue

Regional analysis of Global Pompe Disease market supply, consumption, and export import

Type-based market analysis of global Pompe Disease production, revenue, and price trends

Application-based analysis of the global Pompe Disease market

Manufacturer profiles, manufacturing cost, and upstream and downstream analysis of global Pompe Disease market

Global Pompe Disease market forecast (2022-2030)

Conclusion of the research report

Appendix

Request a customization of the report @ https://www.emergenresearch.com/request-for-customization/1081

Thank you for reading the research report. To get more information about the customized report and customization plan, kindly connect to us and we will provide you with the well-suited customized report.

Take a Look at our other Reports:

Diaper Market https://www.emergenresearch.com/industry-report/diaper-market

Dark Fiber Market https://www.emergenresearch.com/industry-report/dark-fiber-market

Polyphthalamide Market https://www.emergenresearch.com/industry-report/polyphthalamide-market

Hardware Security Modules Market https://www.emergenresearch.com/industry-report/hardware-security-modules-market

Syngas Market https://www.emergenresearch.com/industry-report/syngas-market

Condom Market https://www.emergenresearch.com/industry-report/condom-market

Gamification Market https://www.emergenresearch.com/industry-report/gamification-market

Electric Vehicle Car Polymers Market https://www.emergenresearch.com/industry-report/electric-vehicle-car-polymers-market

About Us:

At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read Full Press Release @ https://www.emergenresearch.com/press-release/global-pompe-disease-market

 


Janna Shar

37 Blog posts

Comments